APA (7th ed.) Citation

Lew, M. F., Slevin, J. T., Krüger, R., Martínez Castrillo, J. C., Chatamra, K., Dubow, J. S., . . . Fung, V. S. (2015). Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials. Parkinsonism & related disorders, 21(7), 742-748. https://doi.org/10.1016/j.parkreldis.2015.04.022

Chicago Style (17th ed.) Citation

Lew, Mark F., John T. Slevin, Rejko Krüger, Juan Carlos Martínez Castrillo, Krai Chatamra, Jordan S. Dubow, Weining Z. Robieson, Janet A. Benesh, and Victor S.C Fung. "Initiation and Dose Optimization for Levodopa-carbidopa Intestinal Gel: Insights from Phase 3 Clinical Trials." Parkinsonism & Related Disorders 21, no. 7 (2015): 742-748. https://doi.org/10.1016/j.parkreldis.2015.04.022.

MLA (9th ed.) Citation

Lew, Mark F., et al. "Initiation and Dose Optimization for Levodopa-carbidopa Intestinal Gel: Insights from Phase 3 Clinical Trials." Parkinsonism & Related Disorders, vol. 21, no. 7, 2015, pp. 742-748, https://doi.org/10.1016/j.parkreldis.2015.04.022.